[Enhancement Effects and Mechanisms of Microscale Zero Valent Iron on the Performance of Anaerobic Co-digestion of Waste Activated Sludge and Food Waste].

Focusing on low biogas yields in the anaerobic co-digestion of waste activated sludge and food waste, the enhancing effects and mechanisms of microscale zero valent iron (mZVI) on anaerobic co-digestion was investigated. The results indicated that the addition of mZVI enhanced the methanogenesis stage of co-digestion but had no significant effect on the solubilization, hydrolysis, and acidification stages. With a dosage of 10 g·L-1 mZVI, the cumulative methane yield (based on VS) within 15 days reached 238.68 mL·g-1, which was 20.05% higher than the control group. The mechanism analysis showed that mZVI promoted electron transport system (ETS) activity (based on INTF/TS), which increased to 21.50 mg·(g·h)-1 with 10 g·L-1 mZVI compared to 13.43 mg·(g·h)-1 in the control group. Furthermore, mZVI enhanced direct interspecies electron transfer (DIET) between specific bacteria and methanogens. Microbial community analysis demonstrated that the abundance of DIET-related microorganisms, such as Syntrophomonas, Methanosarcina, and Methanobacterium, was higher in presence of mZVI.

[Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer].

OBJECTIVE: To study the effect of extract of Ginkgo biloba (Egb761) on doxorubicin-associated cardiotoxicity in patients with breast cancer (BC). METHODS: Sixty BC patients in stage IV were randomly assigned to two groups, the control group was treated with chemotherapy, using 4 cycles of PA protocol alone and the treated group with the same chemotherapy and Egb761. Changes in electrocardiogram (ECG), myocardial enzyme spectrum (MES) and ultrasono-cardiogram (USCG) before and after treatment were observed. RESULTS: After treatment, the incidence of abnormal ECG was lower in the treated group than in the control group (6.7% vs 30.0%); significant differences were found between the two groups in the parameters of MES (P< 0.05); USCG showed significant difference between the two groups in left ventricular diastolic diameter (LVDd), left ventricular systolic diameter (LVDs), ratio of early and late diastolic transmitral peak flow velocity (E/A) and fractional shortening (FS), while there was no significant difference in ejection fraction (EF). CONCLUSION: Egb761 is an ideal drug for preventing and reducing the acute doxorbincin-induced cardiotoxicity; it could also be helpful for alleviating the chronic cardiotoxicity.